Kaiser Permanente Shows Lower Prescription Drug Costs in Washington Compared to Market Benchmark

A study commissioned by Kaiser Permanente Washington found that its prescription drug costs were significantly lower than those of a matched commercial population in Washington. The analysis showed 26% lower costs for HMO plans and 15% for PPO plans, with savings of $21.52 and $15.56 per member per month, respectively.

By Kaiser Permanente · PR Newswire ·

Kaiser Permanente Shows Lower Prescription Drug Costs in Washington Compared to Market Benchmark

Tickers: $MLM

Topics: employer health plans healthcare costs Kaiser Permanente Milliman study pharmacy savings

Read the full article at PR Newswire

More Health news